Fumio Nakamura
   Department   School of Medicine, School of Medicine
   Position   Professor and Division head
Article types Original article
Language English
Peer review Peer reviewed
Title Immunoreactivity of a G protein-coupled l-DOPA receptor GPR143, in Lewy bodies.
Journal Formal name:Neuroscience research
Abbreviation:Neurosci Res
ISSN code:18728111/01680102
Domestic / ForeginForegin
Volume, Issue, Page 148,pp.49-53
Author and coauthor Goshima Yoshio, Watanabe Shuya, Seki Erika, Koga Motokazu, Masukawa Daiki, Nakamura Fumio, Komori Takashi, Arai Nobutaka
Publication date 2019/11
Summary l-3,4-Dihydroxyphenylalanine (l-DOPA) has been believed to be an inert amino acid precursor of dopamine, and is the most effective therapeutic agent in Parkinson's disease (PD). We proposed l-DOPA as a neurotransmitter in the central nervous system. Recently, the ocular albinism 1 gene product, OA1/GPR143 (GPR143), was identified as a receptor for l-DOPA. In this study, we examined by generating anti-human GPR143 antibody, the localization of GPR143-immunoreactive signals in the brains from control and PD subjects. GPR143-immunoreactive signals were detected throughout the entire midbrain including substantia nigra pars compacta. In the PD brains, we found that GPR143-immunoreactive signals were detected in Lewy bodies and were colocalized with immunoreactive signals with anti-human Ser129 phosphorylated α-synuclein antibody. Although the significance of its occurrence in the inclusion bodies is unknown, our finding suggests possible implications of GPR143 in PD.
DOI 10.1016/j.neures.2018.12.004
PMID 30590075